drug-development – Page 7

New tool to measure outcomes in Huntington’s Disease clinical trials

A better tool for HD trials! New research shows innovative way to measure mutant Huntingtin outside the brain

By Megan Krench

September 3, 2015

Day 2 of updates from the annual HD Therapeutics Conference in Palm Springs

February 26, 2015

Day 1 of updates from the annual HD Therapeutics Conference in Palm Springs

February 25, 2015

HD drug changes DNA folding across generations

February 9, 2015

Weighing the scales on mTORC1: A possible new target for HD therapeutics?

January 27, 2015

A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.

November 4, 2014

The largest ever HD drug trial, testing coenzyme Q10, is halted for 'futility'. What does that mean for HD research?

August 13, 2014

Does a specific amino acid deficiency contribute to the development of HD?

April 21, 2014

Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease

April 10, 2014

HDBuzz reports from the opening day of science sessions at the 2014 HD Therapeutics Conference in Palm Springs.

February 26, 2014